CDNA vs SHC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 29, 2026
CDNA
SHC
Investment Advisor Scores
SHC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CDNA | SHC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 156.25 | 17.762 | SHC |
| PEG Ratio | -0.12 | 1.6829 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 52.2% | 9.2% | CDNA |
| Earnings Growth | 0.0% | 569.5% | SHC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.0/100 | 62.5/100 | SHC |
| Profit Margin | 24.2% | 13.4% | CDNA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | SHC |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CDNA
MarkupPrice above SMA50, rising 50-day trend (24.8% over 20 days), RSI 81
SHC
NeutralMixed signals - no dominant trend phase, RSI 43
Fundamentals Snapshot
| Metric | CDNA | SHC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 51.3 | 16.9 |
| Trailing P/E | 30.8 | 32.4 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.5% | 0.1% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.0% | 0.4% |
| EPS | 2.11 | 0.57 |
| Dividend Yield | — | — |